drug · small molecule
OXYCODONE AND ACETAMINOPHEN
updated 5mo agoby $IGC IGC Pharma, Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN660 co-mentions · 335 sources
- tagApproval648 co-mentions · 324 sources
- drugXTAMPZA ER326 co-mentions · 326 sources
- drugoxycodone ER326 co-mentions · 326 sources
- tagSmall Molecule324 co-mentions · 324 sources
- companyActavis Elizabeth LLC43 co-mentions · 43 sources
- companySpecGx LLC19 co-mentions · 18 sources
- companyAurolife Pharma LLC15 co-mentions · 15 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 18 approved and 81 investigational indications.
targets
CyclooxygenaseFatty-acid amide hydrolase 1Transient receptor potential cation channel subfamily V member 1
all catalysts(0)
nothing on the calendar yet
Trials studying OXYCODONE AND ACETAMINOPHEN
- phase3A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
- phase1A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- phase3A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain
- phase3A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- phase3Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
- phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- phase3A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- phase3SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
News(8)
- Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.stat · 9d ago
- Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearingThe Senate Committee on Health, Education, Labor and Pensions (HELP) today questioned Heidi Overton, M.D., Ph.D., Trump’s pick for FDA commissioner, in a hearing marked by tightrope-walking on issu…fiercebiotech · 10d ago
- Opinion: ClinicalTrials.gov needs a pregnancy and lactation checkboxIt’s hard to identify which clinical trials pregnant and lactating patients can join. Here’s one fix, experts write.stat · 13d ago
- Kennedy announces new effort to speed up autism diagnosesHealth secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdatedstat · 17d ago
- ARPA-H launches SPECTRA program, new autism research initiativeResearchers will create an end-to-end system to identify ASD risk factors, connect patients to appropriate interventions and accelerate clinical research for new therapies.fiercebiotech · 17d ago
- STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug JournavxLatigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the marketstat · 2mo ago
- STAT+: TrumpRx adds generic drugsA deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.stat · 4mo ago
- STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHAExamining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, peptides, diet and more.stat · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that